Soundcast - Podcast Responsive Theme

Drug Supply Chain Security Act & Your Pharmacy

Gregory Smith, Ph. D., Inorganic Chemistry  Greg has co-authored 14 technical papers and formal presentations, in addition to occasional blogging here and […]

">
September 01, 2015 Community Pharmacy, Compounding, Institutional Pharmacy, Latest News, Podcasts, Politics & Industry Trends

Gregory Smith, Ph. D., Inorganic Chemistry 

Greg has co-authored 14 technical papers and formal presentations, in addition to occasional blogging here and on LinkedIn and informal presentations to clients and technologists on innovation and new product discovery.  He is an inventor on 10 unique patents or patent applications.Gregory has 30 years of professional experience, building upon a doctorate in chemistry from Northwestern University in organometallic chemistry and a bachelor’s degree in chemistry from MIT.  Greg’s professional experience prior to starting ScienceSmith Consulting included work at Dow Chemical, Akzo Nobel, and Millennium Cell, on topics ranging from organometallic catalysis including olefin polymerization, polymer processing, high purity organometallics to work on chemical processing and fuel cell technologies.

Gregory Smith President,

ScienceSmith Consulting, Inc.

https://www.linkedin.com/in/sciencesmith

Drug Supply Chain Security Act (DSCSA)

http://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity/DrugSupplyChainSecurityAct/

The Drug Quality and Security Act (DQSA), was signed into law by President Obama on November 27, 2013. Title II of DQSA, the Drug Supply Chain Security Act, outlines critical steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States.

Ten years after enactment, the system will facilitate the exchange of information at the individual package level about where a drug has been in the supply chain. The new system will:

  • enable verification of the legitimacy of the drug product identifier down to the package level;
  • enhance detection and notification of illegitimate products in the drug supply chain; and
  • facilitate more efficient recalls of drug products.

Drug manufacturers, wholesale drug distributors, repackagers, and many dispensers (primarily pharmacies) will be called on to work in cooperation with FDA to develop the new system over the next 10 years.

Is Your Pharmacy Ready for Drug Supply Chain Integrity? 

http://www.natlawreview.com/article/your-pharmacy-ready-drug-supply-chain-integrity



Leave a comment